VCP
GDRX icon

Verus Capital Partners’s GoodRx Holdings GDRX Stock Holding History

Verus Capital Partners’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,230
Closed -$55.9K – 424
2025
Q2 		$55.9K Sell
11,230
-6,000
-35% -$26.1K 0.01% 369
2025
Q1 		$76K Buy
17,230
+5,355
+45% +$25.1K 0.01% 372
2024
Q4 		$67.3K Buy
+11,875
New +$65.3K 0.01% 358

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Verus Capital Partners's GDRX Position: Q3 2025 in Review

Verus Capital Partners sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 11,230 shares — an estimated $55.9K sold.

Verus Capital Partners first reported a position in GDRX in Q4 2024 and held it in 3 quarters. The position peaked at $76K in Q1 2025. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Verus Capital Partners reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • Verus Capital Partners sold 11,230 GoodRx Holdings shares in Q3 2025, an estimated $55.9K.
  • Verus Capital Partners first reported a position in GoodRx Holdings in Q4 2024 and held it in 3 quarters.
  • Verus Capital Partners's GoodRx Holdings position peaked at $76K in Q1 2025.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Verus Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.